Reata Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc.（RETA）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
reta · 股价预测 · 10 位分析师（近3月）· FMP · 更新于 2024年3月26日
分析师评级与共识
基于过去 3 个月内 10 位华尔街分析师
Hold
10 位分析师
共识
评级分布
12 个月目标价
High
$115
Consensus
$62.67
-63.6% upside
Low
$27.00
Median: $46 · Last Close: $172.36
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$62.67
-63.6% upside
High Target
$115
-33.3%
Low Target
$27
-84.3%
Current Price
$172.36
as of today
Based on analyst price targets, the RETA stock price prediction for the next 12 months ranges from $27 to $115. The consensus RETA price forecast of $62.67 implies -63.6% upside from the current price of $172.36.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $172.29 | ↓ 0.04% |
1-day model range: $172.24–$172.35. Peak: $172.35 (-0.04%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · RETA · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2023-08-15 | Cantor Fitzgerald | Maintains | Neutral→Neutral |
| 2023-08-14 | Cantor Fitzgerald | Maintains | Neutral→Neutral |
| 2023-08-01 | Citigroup | Downgrade ↓ | Buy→Neutral |
| 2023-08-01 | Barclays | Downgrade ↓ | Overweight→Equal Weight |
| 2023-07-31 | Jefferies | Downgrade ↓ | Buy→Hold |
| 2023-07-31 | Citigroup | Downgrade ↓ | Buy→Neutral |
| 2023-07-31 | Barclays | Downgrade ↓ | Overweight→Equal Weight |
| 2023-07-31 | Ladenburg Thalmann | Downgrade ↓ | Buy→Neutral |
| 2023-07-31 | Baird | Maintains | Outperform→Outperform |
| 2023-07-30 | Ladenburg Thalmann | Downgrade ↓ | Buy→Neutral |
Wall Street analysts have recently issued updated ratings on Reata Pharmaceuticals, Inc. (RETA) stock. Of the recent 102 rating actions, 4 were upgrades and 16 were downgrades. 10 analysts currently cover RETA.
分析师推荐趋势
RETA analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 6 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
—
Revenue Next Year
—
EPS This Year
—
EPS Next Year
—
EPS ForecastReported vs Estimated
Analysts forecast RETA EPS of $— for the current fiscal year, based on estimates from 0 analysts. The RETA revenue forecast is — for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
RETA 股价预测由两类独立数据源支撑：来自 10 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。RETA 的共识目标价为 $62.67（-63.6% 上行空间），分析师共识为 Hold。
RETA 的短期预测（明日）为 $172.29（-0.04%）。
Reata Pharmaceuticals, Inc. 在 NASDAQ 上市，代码 RETA。RETA 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 40% 对应 Hold 共识。
常见问题
RETA 预测 · 8 个问题根据 10 位华尔街分析师，RETA 的 12 个月平均目标价为 $62.67，最高 $115.00、最低 $27.00。若有图表，中位目标价可在上方查看。相对当前价 $172.36，隐含约 -63.6% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.